PARP Inhibition in Prostate Cancer: An Evolving Paradigm and the Role of the Practicing Urologist
English
Recorded Courses
hosted by Clinical Care Options (CCO), LLC
hosted by Clinical Care Options (CCO), LLC
attend it anywhere online
category
Medicine, Healthcare Management
Urology, Oncology
price
Free
PARP Inhibition in Prostate Cancer: An Evolving Paradigm and the Role of the Practicing Urologist is organized by Clinical Care Options (CCO), LLC.,Released: November 30, 2022,Expiration: November 29, 2023,Goal:,The goal of this activity is to improve the knowledge, confidence, and competence of learners to integrate PARP inhibitors and recent findings into the treatment of patients with prostate cancer.,Learning Objectives:,Upon completion of this activity, participants should be able to:,• Describe the medical need and rationale for PARP inhibitors and PARP inhibitor–based combinations in prostate cancer, with or without DNA damage repair alterations,• Obtain tumor tissue and assure that it is tested for DNA damage repair alterations to meet the currently approved use of PARP inhibitors for the treatment of prostate cancer,• Appraise the available clinical evidence and clinical trial strategies using PARP inhibitor–based combinations for prostate cancer in metastatic and earlier stages of disease with or without DNA damage repair alterations,• Identify patients suitable for enrollment on ongoing clinical studies investigating PARP inhibitor combinations in prostate cancer,Additional details will be posted as soon as information is available.